Surveillance and Correlation of Antibiotic Consumption and Resistance of Acinetobacter baumannii complex in a Tertiary Care Hospital in Northeast China, 2003–2011

Jiancheng Xu, Zhihui Sun, Yanyan Li and Qi Zhou
Additional contact information
Jiancheng Xu: Department of Laboratory Medicine, First Hospital of Jilin University, Changchun 130021, China
Zhihui Sun: Department of Pharmacy, First Hospital of Jilin University, Changchun 130021, China
Yanyan Li: Department of Pharmacy, First Hospital of Jilin University, Changchun 130021, China
Qi Zhou: Department of Pediatrics, First Hospital of Jilin University, Changchun 130021, China

IJERPH, 2013, vol. 10, issue 4, 1-12

Abstract: This study investigated the changes in resistance of Acinetobacter baumannii complex and the association of carbapenem-resistant A. baumannii complex (CRAB) infection and hospital antimicrobial usage from 2003 to 2011 in a tertiary care hospital in northeast China. In vitro susceptibilities were determined by disk diffusion test and susceptibility profiles were determined using zone diameter interpretive criteria, as recommended by the Clinical and Laboratory Standards Institute (CLSI). Data on consumption of various antimicrobial agents, expressed as defined daily dose/1,000 patients/day, were collected retrospectively from hospital pharmacy computer database. Most of 2,485 strains of A. baumannii complex were collected from respiratory samples (1,618 isolates, 65.1%), secretions and pus (465, 18.7%) over the years. The rates of antimicrobial resistance in A. baumannii complex increased significantly over the years. The rates of CRAB were between 11.3% and 59.1% over the years. The quarterly use of anti-pseudomonal carbapenems, but not other classes of antibiotics, was strongly correlated with the increase of quarterly CRAB (? = 1.661; p < 0.001). Dedicated use of anti-pseudomonal carbapenems would be an important intervention to control the increase of CRAB.

Keywords: Acinetobacter baumannii complex; drug resistance, microbial; antimicrobials susceptibility test; drug monitoring; antibiotic consumption (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2013
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/10/4/1462/pdf (application/pdf)
https://www.mdpi.com/1660-4601/10/4/1462/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:10:y:2013:i:4:p:1462-1473:d:24823

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().